Phoenix, AZ, United States of America

Christine Branger

This inventor holds 1 USPTO granted patent. Top assignee: Arizona State University. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christine Branger. Retrieved from https://idiyas.com/inventor/christine-branger

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 26(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Christine Branger: Innovator in Immunology

Introduction

Christine Branger is a notable inventor based in Phoenix, AZ (US). She has made significant contributions to the field of immunology through her innovative research and inventions. Her work focuses on developing solutions to combat enteric pathogens, which pose serious health risks.

Latest Patents

Christine Branger holds a patent for a recombinant bacterium capable of eliciting an immune response against enteric pathogens. This invention relates to a recombinant bacterium that can stimulate an immune response against at least two enteric pathogens without significantly inducing an immune response specific to the serotype of the bacterium. The patent also encompasses methods for creating such a bacterium, as well as vaccines and methods for utilizing it.

Career Highlights

Christine is affiliated with Arizona State University, where she continues her research and development efforts. Her work has garnered attention for its potential impact on public health and disease prevention.

Collaborations

Some of her notable coworkers include Roy Curtiss, III, and Melha Mellata. Their collaborative efforts contribute to advancing research in the field of immunology.

Conclusion

Christine Branger is a pioneering inventor whose work in immunology is making strides in the fight against enteric pathogens. Her innovative approaches and dedication to research are paving the way for future advancements in vaccine development and disease prevention.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…